Literature DB >> 10493579

Ca2+-dependent activity of human DNase I and its hyperactive variants.

C Q Pan1, R A Lazarus.   

Abstract

We have recently constructed hyperactive human deoxyribonuclease I (DNase I) variants that digest double-stranded DNA more efficiently under physiological saline conditions by introducing positively charged amino acids at eight positions that can interact favorably with the negatively charged DNA phosphates. In this study, we present data from supercoiled DNA nicking, linear DNA digestion, and hyperchromicity assays that distinguish two classes of DNase I hyperactive variants based upon their activity dependence on Ca2+. Class A variants are highly dependent upon Ca2+, having up to 300-fold lower activity in the presence of Mg2+ alone compared to that in the presence of Mg2+ and Ca2+, and include Q9R, H44K, and T205K, in addition to wild-type DNase I. In contrast, the catalytic activity of Class B variants, which comprise the E13R, T14K, N74K, S75K, and N110R hyperactive variants, is relatively Ca2+ independent. A significant proportion of this difference in Ca2+-dependent activity can be attributed to one of the two structural calcium binding sites in DNase I. Compared to wild-type, the removal of Ca2+ binding site 2 by alanine replacements at Asp99, Asp107, and Glu112 decreased activity up to 26-fold in the presence of Mg2+ and Ca2+, but had no effect in the presence of Mg2+ alone. We propose that the rate-enhancing effect of Ca2+ binding at site 2 can be replaced by favorable electrostatic interactions created by proximal positively charged amino acid substitutions such as those found in the Class B variants, thus reducing the dependence on Ca2+.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493579      PMCID: PMC2144401          DOI: 10.1110/ps.8.9.1780

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  23 in total

Review 1.  Management of pulmonary disease in patients with cystic fibrosis.

Authors:  B W Ramsey
Journal:  N Engl J Med       Date:  1996-07-18       Impact factor: 91.245

2.  Hyperactivity of human DNase I variants. Dependence on the number of positively charged residues and concentration, length, and environment of DNA.

Authors:  C Q Pan; R A Lazarus
Journal:  J Biol Chem       Date:  1998-05-08       Impact factor: 5.157

3.  Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism.

Authors:  C Q Pan; R A Lazarus
Journal:  Biochemistry       Date:  1997-06-03       Impact factor: 3.162

4.  Expression and characterization of a DNase I-Fc fusion enzyme.

Authors:  M A Dwyer; A J Huang; C Q Pan; R A Lazarus
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

Review 5.  DNA recognition by DNase I.

Authors:  D Suck
Journal:  J Mol Recognit       Date:  1994-06       Impact factor: 2.137

6.  Site-directed mutagenesis of phosphate-contacting amino acids of bovine pancreatic deoxyribonuclease I.

Authors:  S J Evans; E J Shipstone; W N Maughan; B A Connolly
Journal:  Biochemistry       Date:  1999-03-30       Impact factor: 3.162

7.  Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence.

Authors:  C Q Pan; J S Ulmer; A Herzka; R A Lazarus
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

8.  Site-directed mutagenesis of the catalytic residues of bovine pancreatic deoxyribonuclease I.

Authors:  S J Jones; A F Worrall; B A Connolly
Journal:  J Mol Biol       Date:  1996-12-20       Impact factor: 5.469

9.  The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone.

Authors:  M Macanovic; D Sinicropi; S Shak; S Baughman; S Thiru; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1996-11       Impact factor: 4.330

10.  Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus.

Authors:  C Q Pan; T H Dodge; D L Baker; W S Prince; D V Sinicropi; R A Lazarus
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  8 in total

1.  Direct real-time molecular scale visualisation of the degradation of condensed DNA complexes exposed to DNase I.

Authors:  Hosam G Abdelhady; Stephanie Allen; Martyn C Davies; Clive J Roberts; Saul J B Tendler; Philip M Williams
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

2.  The distinctive functions of the two structural calcium atoms in bovine pancreatic deoxyribonuclease.

Authors:  Ching-Ying Chen; Shao-Chun Lu; Ta-Hsiu Liao
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

3.  Affinity proteomics to study endogenous protein complexes: pointers, pitfalls, preferences and perspectives.

Authors:  John LaCava; Kelly R Molloy; Martin S Taylor; Michal Domanski; Brian T Chait; Michael P Rout
Journal:  Biotechniques       Date:  2015-03-01       Impact factor: 1.993

4.  How cations can assist DNase I in DNA binding and hydrolysis.

Authors:  Marc Guéroult; Daniel Picot; Joséphine Abi-Ghanem; Brigitte Hartmann; Marc Baaden
Journal:  PLoS Comput Biol       Date:  2010-11-18       Impact factor: 4.475

5.  Pharmacology, pharmacokinetics, and metabolism of the DNA-decoy AYX1 for the prevention of acute and chronic post-surgical pain.

Authors:  Julien Mamet; Scott Harris; Michael Klukinov; David C Yeomans; Renee R Donahue; Brad K Taylor; Kelly Eddinger; Tony Yaksh; Donald C Manning
Journal:  Mol Pain       Date:  2017-01       Impact factor: 3.395

6.  Rpn (YhgA-Like) Proteins of Escherichia coli K-12 and Their Contribution to RecA-Independent Horizontal Transfer.

Authors:  Anthony W Kingston; Christine Ponkratz; Elisabeth A Raleigh
Journal:  J Bacteriol       Date:  2017-03-14       Impact factor: 3.490

7.  Structural characterization of Class 2 OLD family nucleases supports a two-metal catalysis mechanism for cleavage.

Authors:  Carl J Schiltz; April Lee; Edward A Partlow; Christopher J Hosford; Joshua S Chappie
Journal:  Nucleic Acids Res       Date:  2019-09-26       Impact factor: 16.971

8.  Actin-Resistant DNase1L2 as a Potential Therapeutics for CF Lung Disease.

Authors:  Danila Delfino; Giulia Mori; Claudio Rivetti; Antonella Grigoletto; Gloria Bizzotto; Cristian Cavozzi; Marco Malatesta; Davide Cavazzini; Gianfranco Pasut; Riccardo Percudani
Journal:  Biomolecules       Date:  2021-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.